Using our dataset and another high-quality dataset, we identified proteins that showed clinical prognosis and recurrence associations, of which GGACT, LXN, THY1, SYNPO2, ACMSD and COLEC11 were unique biomarkers identified from NAT that could not be revealed using tumor-based analysis. Here, BRD2 is linked to neoplasm.